Abstract
In 1898, Cantacuzene (1) reported that rodent phagocytes exposed to morphine had reduced phagocytic and chemotactic activity in both in vitro and in vivo experimental systems. This work was carried out in the laboratory of the father of cell-mediated immunology, Elie Metchnikoff, and represents the first rigorous scientific study aimed at characterizing the immunological effects of opiates. About 10 years later, Archard et al., (2) corroborated the findings of Cantacuzene (1). By 1928, evidence indicating the immunomodulatory potential of opiates was reviewed by Terry and Pellens (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. Cantacuzene, Nouvelles recherches sur le mode de destruction des vibrions dans l’orgamsme. Annals Institute de Pasteur 12:274 (1898).
C. Archard, H. Bernard, and C. Gagneux, Action de la morphine sur les proprietes leucocytaires: leuka-diagnostic du morphiniseme, Bulletin Mem. Soc. Med. Hopitauz de Paris 28:958 (1909).
C. E. Terry, and M. Pellens, The Opium Problem”. New York: Bureau of Social Hygiene, (1928).
H. H. Hussey, and S. Katz, Infections resulting from narcotic addiction; report of 102 cases. Am. J. Med. 9:186 (1950).
J. D. Sapira, The narcotic addict as a medical patient, Am. J. Med. 45:555 (1968).
D. B. Louria, Infectious complications of nonalcoholic drug abuse, Ann. Rev. Med. 25:219 (1974).
W. E. Dismukes, A. W. Karchmer, R. F. Johnson, and W. J. Dougherty, Viral hepatitis associated with illicit parenteral use of drugs. JAMA. 206:1048 (1968).
S. W. Brown, B. Stimmel ,R. N. Taub, S. Kochwa, and R. E. Rosenfield, Immunological dysfunction in heroin addicts. Arch. Intern. Med. 134:1001 (1974).
A. Falek, R. B. Jordan, B. S. King, P. J. Arnold, and W. B.Skelton, Human chromosomes and opiates. Arch. Gen. Psychiat. 27:511 (1972).
R. J. McDonough, J. J. Madden, A. Falek, D. A. Shafer, M. Pline, D. Gordon, P. Bokos, J. C. Kuehnle, and J. Mendelson, Alteration of T and null lmphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence of opiate receptor sites on T-lymphocytes, J. Immunol. 124: 2539 (1980).
J. Wybran, T. Appelboom, J. P. Famaey, and A. Goverts, Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T-lymphocytes. J. Immunol. 123:1068 (1979).
J. J. Madden and R. M. Donahoe, Opiate binding to cells of the immune system, in: “Drugs of abuse and immune function,” Watson, R.R. (ed), CRC Press, Inc., Boca Raton, FL, pp. 213–228, (1980).
D. D. Taub, T. K. Eisenstein, E. G. Geller, M. W. Adler, and T. J.Rogers, Immunomodulatory activity of mu-and kappa-selective opioid agonist, Proc. Natl. Acad. Sci. ,U.S.A. 88:360 (1991).
Y. Shavit, A. Depaulis, R. D. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale, and J. C. Liebeskind, Involvement of brain opiate receptors in the immune-suppressive effects of morphine, Proc. Natl. Acad. Sci. ,U.S.A. 83: 7114 (1986).
R. J. Weber, and A. Pert, The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188 (1989).
D. C. Des Jarlais, S. R. Friedman, M. Marmor, H. Cohen, D. Mildran, S. Vancovitz, U. Mathur, W. El-Sadr, T. J. Spira, J. Garber, S. T. Beatrice, A. S. Abdul-Quader, and J. L. Sotheran, Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users, AIDS 1:105 (1987).
R. L. Stoneburner, D. Des Jarlais, D. Benezra, L. Gorelkin, J. L. Sotheran, S. R. Friedman, S. Schultz, M. Marmor, D. Mildvan, and R. Maslansky, A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City, Science 242:916 (1988).
R. A. Kaslow, W. C. Blackwelder, D. G. Ostrow, D. Yerg, J. Palenicek, A. H. Coulson, and R. O. Valdiserri, No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. JAMA. 261:3424 (1989).
K. M. Farizo, J. W.Buehler, M. E. Chamberland, B. M. Whyte, E. S. Froelicher, S. G. Hopkins, C M.Reed, E. D. Makotoff, D. L. Cohn, S. Troxler, A. F. Phelps, and R. L. Berkelman, Spectrum of disease in persons with human immunodeficiency virus infection in the United States, JAMA. 267:1798 (1992).
J. M. Zenilman, B. Erickson, R. Fox, C. A. Reichart, and E. W. Hook, III. Effect of HIV posttest counseling on STD incidence, J.A.M.A. 267:843 (1992).
Letters to Editor, Psychoactive drug use and AIDS, JAMA. 263:371 (1990).
P. N. Fultz, A. M. McClure, D. C. Anderson, R. B. Swenson, R. Anand, and A. Srinivasan, Isolation of a T-lymphotropic retrovirus from naturally infected sooty managabey monkeys (Cercocebus atys). Proc. Natl. Acad. ,Sci. ,U.S.A. 83:5286 (1986).
H. M. McClure, D. C. Anderson, P. N. Fultz, A. A. Ansari, E. Lockwood, and A. Brodie, Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet. Immunol. Immunopathol. 21:13 (1989).
J. H. Woods, G. D. Winger, F. Medzihradsky, C. B. Smith, D. Gemerek, M. D. Aceto, L. S. Harris, E. L. May, R. L. Balster, and B. L. Slifer, Evaluation of new compounds for opioid activity in rhesus monkey, rat and mouse, NIDA Res. Monograph Ser. 55:309 (1984).
R. M. Donahoe, and A. Falek, Neuroimmunomodulation by opiates and other drugs of abuse: Relationship to HIV infection and AIDS, Adv. Bioch. Psychopharmacol. 44:145 (1988).
P. N. Fultz, H. M. McClure, D. C. Anderson, and W. M. Switzer, Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res. Hu. Retrovirol 5:397 (1989).
M. I. Bukrinsky, T. L. Stanwick, M. P. Dempsey, and M. Stevenson, Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423 (1991).
V. Riley, Psychoneurocendocrine influences on immunocompetence and neoplasia, Science 212: 1100 (1981).
D. D. Ho, T. Moudgil ,and M. Alam, Quantitation of human immunodeficiency virus type 1 in the blood of infected persons, N.E.J.M. 321:1622 (1989).
A. S. Fauci, S. M. Schnittman, G. Poli, S. Koenig, and G. Pantaleo, NIH Conference. Immunopatho-genic mechanisms in human immunodeficiency virus infection, Ann. Inern. Med. 114:678 (1991).
Y. Shavit, G. W. Terman, J. W. Lewis, C. J. Zane, R. P. Gale, and J. C. Liebeskind, Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance, Brain Res. 372:382 (1986).
S. Tross, and D. A. Hirsch, Psychological distress and neuropsychological complications of HTV infection and AIDS, Am. Psychologist 43:919 (1988).
J. M. Risdahl, P. K. Peterson, C. Pijoan, and T. W. Molitor, Effects of morphine dependence upon the pathogenesis of swine herpesvirus infection, J. Infec. Dis. Submitted, (1992).
E. Tubaro, G. Borelli, C. Croc, G. Cavallo, and G. Santiangeli, Effect of morphine on resistance to infection, I. Infect. Dis. 148:656 (1983).
E. Tubaro, U. Avico, G. Santiangeli, P. Zucarro, G. Cavallo, R. Pacifici, C. Croce, and G. Vorelli, Morphine and methadone impact on human phagocytic physiology, Int. J. Immunopharmacol. 7:865 (1985)
R. Ader, D. L. Felton, and N. Cohen, Psychoneuroimmunol. (2nd edition), Academic Press, New York, (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Donahoe, R.M. et al. (1993). Consequences of Opiate-Dependency in a Monkey Model of AIDS. In: Friedman, H., Klein, T.W., Specter, S. (eds) Drugs of Abuse, Immunity, and AIDS. Advances in Experimental Medicine and Biology, vol 335. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2980-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2980-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6297-5
Online ISBN: 978-1-4615-2980-4
eBook Packages: Springer Book Archive